PAR 6.67% 24.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-158

  1. 3,031 Posts.
    lightbulb Created with Sketch. 1849
    Please don’t confuse approval for a limited special access trial as “FDA approval” for the drug in general. Yes it is very positive but saying it is already an FDA approved drug is not quite true. IMO.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.0¢
Change
0.015(6.67%)
Mkt cap ! $83.98M
Open High Low Value Volume
22.5¢ 24.0¢ 22.5¢ $173.6K 743.6K

Buyers (Bids)

No. Vol. Price($)
8 99346 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 131244 5
View Market Depth
Last trade - 16.10pm 13/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.